Obesity-induced inflammation (e.g., TNF-α, IL-1β and IFN-γ), as well as TLR4 protein expression and endotoxemia status, was also reduced after 12-week supplementation with L. acidophilus through NF-κB inhibition. The gene discussed is TLR4; the disease is obesity disorder.